Impact of epidermal growth factor receptor (EGFR) activating mutations and their targeted treatment in the prognosis of stage IV non-small cell lung cancer (NSCLC) patients harboring liver metastasis.
Journal of translational medicine | 2015-08-07 | PMID 26248464
Castañón Eduardo, Rolfo Christian, Viñal David and 7 more
Genes: EGFR, ALK, EML4, KRAS
